Rethinking
Non-Invasive Brain
Technologies

Actipulse is changing the aproach on how we treat neurodegenerative disorders.

More about us

A Paris Brain Institute company

Backed by Y Combinator, and with offices in Paris and Cambridge, MA, we specialize in the clinical research of Non-Invasive Brain Stimulation technologies for the treatment of CNS disorders.

Logo Paris Brain Institute Logo Founder x Logo Y combinator

This is why we founded
Actipulse Neuroscience®

We are a neuro-tech company specialized in the research and engineering of Non-Invasive Brain Stimulation technologies for the treatment of psychiatric and neurological disorders.

We are pioneers in Non-Invasive Brain Stimulation technologies with a particular focus on transcranial neuromodulation devices using high frequency magnetic pulses that target multiple well known, but neglected pathogenic mechanisms in neurodegenerative disorders.

Imagen de medicos en ppipeline

Our current
Clinical Pipeline

Actipulse Neuroscience is focused on leading world class research with a particular emphasis on respecting the highest clinical and ethical standards.

Major Depressive Disorder

PHASE 3 PIVOTAL STUDY

Drug delivery

PRE CLINICAL

Oncology 1

PRE CLINICAL

The future golden
standard of
neurodegenerative
treatment

Actipulse Neuroscience has for goal to be the golden standard of neuromodulation technologies in the next five years and to become an integral part of the treatment of the millions of patients suffering from neurological and psychiatric disorders and dementia in the world.

Contact us

We want to tell you about us and how this revolutionary technology will impact the world with your help.